PATENT CLAIM ANALYSIS

Application Number: 15743384
Application Type: Utility
Filing Date: 2018-01
Publication Date: 2018-08
Patent Classification: ["424", "172100"]

Abstract:
The disclosure generally provides compositions and methods that are useful in the treatment of cancer. More specifically, the methods and compositions may be used to detect, quantify, inhibit, kill, differentiate, or eliminate cancer stem cells (CSCs) and may be used in the treatment of cancers associated with CSCs, and particularly cancers and CSCs that express CCL20 and/or CCR6.

Claim (Index 22):
A method for treating cancer in a subject who has recurring or relapsed cancer comprising administering to a subject an inhibitor of CCL20, an inhibitor of CCR6, or a combination thereof, in an amount effective to treat the cancer.

Metadata:
- Claim Count in Document: 36.0
- Percentile: 86.0
- Lexical Diversity: 1.60465
- Patent Class: 424.0
- Transitional Phrase Type: open
- Component Type: 1
- Foreign Priority: False
- Related Applications: ['14899549', '15506469', '15023358', '14380807', '13300352']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7281903516675856
- 35 USC 102 Novelty (BERT): 0.5314637369601914
- Combined Prediction Score: 0.7085176901968462
- Mean Citation Score: 314.050614
- Max Citation Score: 366.30115
- Similarity Product: 288.615280940035

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test